Chairman, Chief Executive Officer and President BD
The COVID-19 pandemic placed medtech at a crossroads between crisis and opportunity, and between the past and a still unknown future that will emerge. While many parts of the industry faced serious financial headwinds, investors exhibited bullish confidence in medtech through record levels of investment. In particular, new diagnostic tools and digital health enablers for at-home care and disease maintenance away from hospitals and clinics drove growth and will do so long after the current crisis abates. However, medtech has yet to fully realize the potential of new digital technologies to transform the industry. Connected devices will capture and analyze data to deliver personalized care and improved outcomes, while presenting new challenges in customer engagement, data management and cybersecurity. EY's 15th annual Pulse of the Industry Medical Technology report examines each of these topics and will be the foundation for the panel conversation where we'll explore how medtech companies can best seize the opportunities and avoid the dangers ahead.